Recent developments in nanoparticle-based photo-immunotherapy for cancer treatment

Summary

This review describes the convergence of nanoparticle phototherapy and cancer immunotherapy. Photothermal agents convert externally applied light into local heat, whereas photodynamic agents generate reactive oxygen species; both can directly destroy cells at an illuminated tumor. Nanoparticles can improve the compatibility of these agents, tune their physicochemical behavior, and increase delivery to tumor tissue. The same carriers can also package multiple components, enabling codelivery strategies intended to strengthen local phototherapeutic effects. More recent work, emphasized by the review, seeks to exploit the immune consequences of light-induced tumor damage rather than treating local ablation as the final endpoint. By combining phototherapy with immune stimulation or regulation, nanoparticle platforms may generate responses that last longer and act against disease beyond the irradiated primary tumor. The article is a field overview, not a report of one new formulation. Its principal significance is framing photo-immunotherapy as a route from local physical destruction toward durable, systemic antitumor control, with nanocarriers coordinating delivery. The abstract does not specify review methods, compare particular materials or immune combinations, or establish clinical efficacy, safety, optimal light penetration, and control of inflammatory toxicity.